As highlighted in the full year results announcement last month, Oncimmune has seen a significant increase in business activity since the end of the summer. A number of deals have been signed with both new and existing customers, leading to a record quarter in terms of contract wins. These include two contract wins with two new large pharma customers investigating SLE, a condition that is currently incurable and difficult to diagnose. In addition, a number of other contracts are in late stage ne ....
07 Dec 2021
Record quarterly sales intake
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Record quarterly sales intake
Oncimmune Holdings Plc (ONC:LON) | 27.6 -0.4 (-5.2%) | Mkt Cap: 20.5m
- Published:
07 Dec 2021 -
Author:
Chris Glasper -
Pages:
3
As highlighted in the full year results announcement last month, Oncimmune has seen a significant increase in business activity since the end of the summer. A number of deals have been signed with both new and existing customers, leading to a record quarter in terms of contract wins. These include two contract wins with two new large pharma customers investigating SLE, a condition that is currently incurable and difficult to diagnose. In addition, a number of other contracts are in late stage ne ....